Medical Enterprises group concentrates on innovative medical devices and technologies. The company is focused on minimally-invasive therapies providing benefits for both patients and healthcare systems. The leading product, Synergo®, is a powerful technology for prophylactic and ablative treatment of Non-Muscle Invasive Bladder Cancer, based on homogenous RF radiation (microwave hyperthermia) of the bladder in combination with chemotherapeutic instillation. Synergo® is CE approved and FDA clinically approved. It is currently used in hospitals throughout Europe, the Middle East and soon also in the United States.
"Medical Enterprises" - Social Networks
Click to visit the social networks of Medical Enterprises:
Please enter your phone number and click "Send" to receive the listing details by SMS.
For numbers outside the US, please enter the country code, for e.g. +91.
If you do not receive a message, your phone number might be registered in the Do Not Disturb Registry.
Number:
For numbers outside the US please enter the country code.
Please enter your phone number and click "Call" to call the listing owner.
Number:
For numbers outside the US please enter the country code.
